title: GA201: a novel humanized and glycoengineered anti-EGFR antibody--response.
authors.affiliation: Authors' Affiliation: Roche Glycart AG, pRED, Schlieren, Switzerland.
authors.forename: Christian A
authors.initials: CA
authors.lastname: Gerdes
authors.forename: Pablo
authors.initials: P
authors.lastname: Umaña
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D000920:Antibody-Dependent Cell Cytotoxicity / Q000187:drug effects*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D066246:ErbB Receptors / Q000378:metabolism*; D005260:Female; D006023:Glycoproteins / Q000494:pharmacology*; D006801:Humans; D060847:Metabolic Engineering; D009369:Neoplasms / Q000276:immunology*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D006023:Glycoproteins; D066246:ErbB Receptors